Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
出版年份 2017 全文链接
标题
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 4, Pages 280-299
出版商
Springer Nature
发表日期
2017-12-08
DOI
10.1038/nrd.2017.221
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Arbaclofen in fragile X syndrome: results of phase 3 trials
- (2017) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety
- (2017) Tori L. Schaefer et al. Journal of Neurodevelopmental Disorders
- A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
- (2017) Andrew Ligsay et al. Journal of Neurodevelopmental Disorders
- Metformin ameliorates core deficits in a mouse model of fragile X syndrome
- (2017) Ilse Gantois et al. NATURE MEDICINE
- Certainty of genuine treatment increases drug responses among intellectually disabled patients
- (2017) Karin B. Jensen et al. NEUROLOGY
- Challenges and Promises of Pediatric Psychopharmacology
- (2016) Lisa L. Giles et al. Academic Pediatrics
- Pharmacotherapy for Fragile X Syndrome: Progress to Date
- (2016) Matthew H. Davenport et al. DRUGS
- N-of-1 trials are a tapestry of heterogeneity
- (2016) Salima Punja et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
- (2016) Laura Greiss Hess et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions
- (2016) David Hessl et al. Journal of Neurodevelopmental Disorders
- Synaptic AMPA receptor composition in development, plasticity and disease
- (2016) Jeremy M. Henley et al. NATURE REVIEWS NEUROSCIENCE
- Impaired cognitive discrimination and discoordination of coupled theta–gamma oscillations in Fmr1 knockout mice
- (2016) Basma Radwan et al. NEUROBIOLOGY OF DISEASE
- Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
- (2016) Elizabeth Berry-Kravis et al. Science Translational Medicine
- Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome
- (2016) L E Ethridge et al. Translational Psychiatry
- Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
- (2016) Maria Gomis-González et al. Genes
- A Novel Analog Reasoning Paradigm: New Insights in Intellectually Disabled Patients
- (2016) Aurore Curie et al. PLoS One
- The GABAAreceptor is an FMRP target with therapeutic potential in fragile X syndrome
- (2015) Sien Braat et al. CELL CYCLE
- Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome
- (2015) Sebastian H Scharf et al. CURRENT OPINION IN PHARMACOLOGY
- R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome
- (2015) Mei Qin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
- (2015) Sara Silva-Santos et al. JOURNAL OF CLINICAL INVESTIGATION
- Convergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/y Mice
- (2015) S. A. Barnes et al. JOURNAL OF NEUROSCIENCE
- Long-Term Outcomes of Early Intervention in 6-Year-Old Children With Autism Spectrum Disorder
- (2015) Annette Estes et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test
- (2015) C.E.F. de Esch et al. NEUROBIOLOGY OF DISEASE
- 7, 8-Dihydroxyflavone induces synapse expression of AMPA GluA1 and ameliorates cognitive and spine abnormalities in a mouse model of fragile X syndrome
- (2015) Mi Tian et al. NEUROPHARMACOLOGY
- Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice
- (2015) Aditi Bhattacharya et al. NEUROPSYCHOPHARMACOLOGY
- GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism
- (2015) J L Silverman et al. NEUROPSYCHOPHARMACOLOGY
- Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
- (2015) Christina Gross et al. Neurotherapeutics
- Increased Expression of the PI3K Enhancer PIKE Mediates Deficits in Synaptic Plasticity and Behavior in Fragile X Syndrome
- (2015) Christina Gross et al. Cell Reports
- Treatment of Cognitive Deficits in Genetic Disorders
- (2015) Thijs van der Vaart et al. JAMA Neurology
- Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis
- (2015) Aurore Curie et al. PLoS One
- AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization
- (2014) Ivo Vranesic et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome
- (2014) Bernadett Boda et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Genetic Removal of Matrix Metalloproteinase 9 Rescues the Symptoms of Fragile X Syndrome in a Mouse Model
- (2014) H. Sidhu et al. JOURNAL OF NEUROSCIENCE
- Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening
- (2014) Maximilian Handt et al. MOLECULAR AND CELLULAR PROBES
- The contribution of de novo coding mutations to autism spectrum disorder
- (2014) Ivan Iossifov et al. NATURE
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Rescue of fragile X syndrome phenotypes in Fmr1KO mice by a BKCa channel opener molecule
- (2014) Betty Hébert et al. Orphanet Journal of Rare Diseases
- Longitudinal Profiles of Adaptive Behavior in Fragile X Syndrome
- (2014) C. Klaiman et al. PEDIATRICS
- Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice
- (2013) Aubin Michalon et al. BIOLOGICAL PSYCHIATRY
- Development of an Expressive Language Sampling Procedure in Fragile X Syndrome
- (2013) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
- (2013) Mary Jacena S. Leigh et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology
- (2013) Tsuyoshi Udagawa et al. NATURE MEDICINE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
- (2013) B. M. Dolan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
- (2013) Craig A. Erickson et al. PSYCHOPHARMACOLOGY
- Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice
- (2012) Ilse Gantois et al. BEHAVIOURAL BRAIN RESEARCH
- Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
- (2012) S. M. Goebel-Goody et al. GENES BRAIN AND BEHAVIOR
- Effectiveness and Safety of Donepezil in Boys With Fragile X Syndrome
- (2012) Jitendra Kumar Sahu et al. JOURNAL OF CHILD NEUROLOGY
- Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
- (2012) Andrew Knox et al. Journal of Neurodevelopmental Disorders
- Regulation of neuronal GABAB receptor functions by subunit composition
- (2012) Martin Gassmann et al. NATURE REVIEWS NEUROSCIENCE
- Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
- (2012) Aditi Bhattacharya et al. NEURON
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review
- (2012) D. Dove et al. PEDIATRICS
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
- (2012) Andreea S. Pop et al. PSYCHOPHARMACOLOGY
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
- (2012) E. M. Berry-Kravis et al. Science Translational Medicine
- Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome
- (2011) Alexia M. Thomas et al. BEHAVIOURAL BRAIN RESEARCH
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- N-of-1 Trials in the Medical Literature
- (2011) Nicole B. Gabler et al. MEDICAL CARE
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome
- (2011) Zhong-Hua Liu et al. NEUROBIOLOGY OF DISEASE
- New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats
- (2011) T.J. Bussey et al. NEUROPHARMACOLOGY
- Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
- (2011) Cara J. Westmark et al. PLoS One
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
- (2011) S. Jacquemont et al. Science Translational Medicine
- Open-label add-on treatment trial of minocycline in fragile X syndrome
- (2010) Carlo Paribello et al. BMC Neurology
- Loss of the Fragile X Mental Retardation Protein Decouples Metabotropic Glutamate Receptor Dependent Priming of Long-Term Potentiation From Protein Synthesis
- (2010) Benjamin D. Auerbach et al. JOURNAL OF NEUROPHYSIOLOGY
- Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome
- (2010) C. Gross et al. JOURNAL OF NEUROSCIENCE
- Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
- (2010) E. K. Osterweil et al. JOURNAL OF NEUROSCIENCE
- Physiological Activation of Synaptic Rac>PAK (p-21 Activated Kinase) Signaling Is Defective in a Mouse Model of Fragile X Syndrome
- (2010) L. Y. Chen et al. JOURNAL OF NEUROSCIENCE
- Aripiprazole in autism spectrum disorders and fragile X syndrome
- (2010) Craig A. Erickson et al. Neurotherapeutics
- Fragile X: Leading the way for targeted treatments in autism
- (2010) Lulu W. Wang et al. Neurotherapeutics
- Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
- (2010) Chi-Tso Chiu et al. PHARMACOLOGY & THERAPEUTICS
- Cholinergic dysfunction in fragile X syndrome and potential intervention: A preliminary1H MRS study
- (2009) Shelli R. Kesler et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
- (2009) Christopher J. Yuskaitis et al. BIOCHEMICAL PHARMACOLOGY
- A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
- (2009) E Berry-Kravis et al. JOURNAL OF MEDICAL GENETICS
- Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model
- (2009) G. Dawson et al. PEDIATRICS
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Acamprosate: Recent Findings and Future Research Directions
- (2008) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Design, power, and interpretation of studies in the standard murine model of ALS
- (2008) Sean Scott et al. Amyotrophic Lateral Sclerosis
- Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS)
- (2008) Charlotte D'Hulst et al. BRAIN RESEARCH
- S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade
- (2008) Usha Narayanan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior
- (2008) Michael G. Aman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
- (2008) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
- (2008) David Hessl et al. Journal of Neurodevelopmental Disorders
- The touchscreen cognitive testing method for rodents: How to get the best out of your rat
- (2008) T. J. Bussey et al. LEARNING & MEMORY
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Advances in the Treatment of Fragile X Syndrome
- (2008) R. J. Hagerman et al. PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started